Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 1726078, 10 pages
https://doi.org/10.1155/2017/1726078
Review Article

Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity

Department of Visceral Surgery, Lausanne University Hospital, Pavillon 4, Av. de Beaumont, 1011 Lausanne, Switzerland

Correspondence should be addressed to Olivier Dormond; hc.vuhc@dnomrod.reivilo

Received 4 November 2016; Accepted 22 January 2017; Published 9 February 2017

Academic Editor: Zhiyou Cai

Copyright © 2017 Seraina Faes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Seraina Faes, Nicolas Demartines, and Olivier Dormond, “Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 1726078, 10 pages, 2017. doi:10.1155/2017/1726078